国际呼吸杂志
國際呼吸雜誌
국제호흡잡지
INTERNATIONAL JOURNAL OF RESPIRATION
2015年
14期
1075-1077
,共3页
结核性胸膜炎%血清%糖类抗原125
結覈性胸膜炎%血清%糖類抗原125
결핵성흉막염%혈청%당류항원125
Tuberculous pleurisy%Serum%Carbohydrate antigen 125
目的 探究结核性胸膜炎患者治疗前后血清糖类抗原125(CA125)水平的变化及其临床意义.方法 选择2010年6月到2013年6月在佛山市第二人民医院进行诊治的62例结核性胸膜炎患者(观察组)及60名健康人(对照组)为研究对象,分别在抗结核治疗前、治疗1个月和3个月后对血清CA125水平进行对比.结果 观察组治疗前血清CA125水平明显高于对照组;观察组患者在抗结核治疗1个月后血清CA125水平比治疗前有显著降低,治疗3个月后血清CA125水平低于治疗1个月后和治疗前水平(P值均<0.01).结论 CA125水平检测可以作为结核性胸膜炎患者诊断和疗效观察的指标之一.
目的 探究結覈性胸膜炎患者治療前後血清糖類抗原125(CA125)水平的變化及其臨床意義.方法 選擇2010年6月到2013年6月在彿山市第二人民醫院進行診治的62例結覈性胸膜炎患者(觀察組)及60名健康人(對照組)為研究對象,分彆在抗結覈治療前、治療1箇月和3箇月後對血清CA125水平進行對比.結果 觀察組治療前血清CA125水平明顯高于對照組;觀察組患者在抗結覈治療1箇月後血清CA125水平比治療前有顯著降低,治療3箇月後血清CA125水平低于治療1箇月後和治療前水平(P值均<0.01).結論 CA125水平檢測可以作為結覈性胸膜炎患者診斷和療效觀察的指標之一.
목적 탐구결핵성흉막염환자치료전후혈청당류항원125(CA125)수평적변화급기림상의의.방법 선택2010년6월도2013년6월재불산시제이인민의원진행진치적62례결핵성흉막염환자(관찰조)급60명건강인(대조조)위연구대상,분별재항결핵치료전、치료1개월화3개월후대혈청CA125수평진행대비.결과 관찰조치료전혈청CA125수평명현고우대조조;관찰조환자재항결핵치료1개월후혈청CA125수평비치료전유현저강저,치료3개월후혈청CA125수평저우치료1개월후화치료전수평(P치균<0.01).결론 CA125수평검측가이작위결핵성흉막염환자진단화료효관찰적지표지일.
Objective To explore serum carbohydrate antigen 125 (CA125) level in patients with tuberculous pleurisy before and after treatment,and its clinical significance.Methods From June 2010 to June 2013,62 cases of tuberculous pleurisy (observation group) and 60 cases of healthy people (control group) were selected as the research objects.The serum CA125 level was detected before treatment and after treatment for one month and three months.Results Serum CA125 level in the patients with tuberculous pleurisy was significantly higher than that in the control group.Serum CA125 level after treatment for one month was significantly lower than that before treatment in the observation group.Serum CA125 level after treatment for three months was lower than that before treatment and after treatment for one month (all P <0.01).Conclusions Serum CA125 level can be used as one of the important indexes of diagnosis and treatment of tuberculous pleurisy.